CD28 and acute lymphoblastic leukemia: The expression of a third-generation anti-CD3 CAR, incorporating CD28 and 4-1BB costimulatory domains, in the NK-92 cell line induced the in vitro and in vivo killing of CD3+ lymphoma cells, primary T cells and T-ALL cells [70].